Patents Assigned to POVIVA CORP.
  • Compositions and methods for treating epilepsy
    Patent number: 12023346
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: July 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 11986485
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: May 21, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating hypertension
    Patent number: 11980593
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: May 14, 2024
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 11944635
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: April 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 11931369
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: March 19, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR SUBLINGUAL DELIVERY OF NICOTINE
    Publication number: 20230301341
    Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
    Type: Application
    Filed: March 22, 2022
    Publication date: September 28, 2023
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for sublingual delivery of nicotine
    Patent number: 11700875
    Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
    Type: Grant
    Filed: March 22, 2022
    Date of Patent: July 18, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating hypertension
    Patent number: 11666544
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: June 6, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Pharmaceutical compositions and methods for treating hypertension
    Patent number: 11666543
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: June 6, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for enhanced delivery of antiviral agents
    Patent number: 11311559
    Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: April 26, 2022
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS
    Publication number: 20220054495
    Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
    Type: Application
    Filed: April 19, 2021
    Publication date: February 24, 2022
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS
    Publication number: 20210330683
    Abstract: Disclosed herein are methods, compositions and kits for treating a viral infection, for example, COVID-19, MERS and SARS. The disclosed compositions provide for enhanced delivery of the disclosed antiviral agents.
    Type: Application
    Filed: April 19, 2021
    Publication date: October 28, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF
    Publication number: 20210289832
    Abstract: Aspects described herein relate to lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof. More particularly, aspects described herein relate to tobacco leaves and/or tobacco materials infused with lipophilic active agents that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes.
    Type: Application
    Filed: September 13, 2019
    Publication date: September 23, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • STABLE READY-TO-DRINK BEVERAGE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20210235716
    Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 5, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF
    Publication number: 20210213091
    Abstract: Aspects described herein relate to lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof. More particularly, aspects described herein relate to tobacco leaves and/or tobacco materials infused with lipophilic active agents that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 15, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20210177978
    Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 17, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • Food and beverage compositions infused with lipophilic active agents and methods of use thereof
    Patent number: 10756180
    Abstract: Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: August 25, 2020
    Assignee: POVIVA CORP.
    Inventors: Michelle Reillo, Marian E. Washington